Terms: = Lymphoma AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Prognosis
1099 results:
1. Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma.
Chen J; Zhou J; Cheng F; Chen D; Guan F; Zhang E; He J; Cai Z; Zhao Y
J Cancer Res Clin Oncol; 2024 Apr; 150(4):181. PubMed ID: 38587664
[TBL] [Abstract] [Full Text] [Related]
2. Ferroptosis mechanisms and its novel potential therapeutic targets for DLBCL.
Bian W; Li H; Chen Y; Yu Y; Lei G; Yang X; Li S; Chen X; Li H; Yang J; Yang C; Li Y; Zhou Y
Biomed Pharmacother; 2024 Apr; 173():116386. PubMed ID: 38492438
[TBL] [Abstract] [Full Text] [Related]
3. A single-centre, real-world study of BTK inhibitors for the initial treatment of MYD88
Deng T; Zhang S; Xiao M; Gu J; Huang L; Zhou X
Cancer Med; 2024 Feb; 13(4):e7005. PubMed ID: 38457222
[TBL] [Abstract] [Full Text] [Related]
4. Primary thyroid lymphoma: a case series.
Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
[TBL] [Abstract] [Full Text] [Related]
5. Diffuse large B-cell lymphoma: the significance of CD8
Zhu Q; Yang Y; Chen K; Zhang Q; Huang Y; Jian S
J Transl Med; 2024 Feb; 22(1):174. PubMed ID: 38369502
[TBL] [Abstract] [Full Text] [Related]
6. Gastric Burkitt's monomorphic post-transplant lymphoproliferative disorder after kidney transplantation: A case report.
Yoshimura Y; Suwabe T; Fujiki A; Kaji D; Asano-Mori Y; Oba Y; Mizuno H; Yamanouchi M; Tanaka K; Hasegawa E; Miki K; Yokoyama T; Namamura Y; Ishii Y; Yamashita S; Kono K; Kinowaki K; Takazawa Y; Sawa N; Ubara Y
Clin Nephrol; 2024 May; 101(5):250-256. PubMed ID: 38329919
[TBL] [Abstract] [Full Text] [Related]
7. Hepatitis B surface antigen positivity is associated with poor short- and long-term outcomes in patients with diffuse large B-cell lymphoma who received chop or R-chop.
Zhan Z; Guo W; Wan X; Wang B; Li J; Wang H; Li Z; Huang Y; Young KH; Bai O
Front Immunol; 2024; 15():1324113. PubMed ID: 38318173
[TBL] [Abstract] [Full Text] [Related]
8. [A Case of Monomorphic Epitheliotropic Intestinal T-Cell lymphoma Causing Perforation of the Small Intestine].
Matsumura T; Koide N; Matsushima T; Wada R; Iwasaki K; Kitamura K; Usui S; Koyama M; Kozaki K; Sato Y; Karikomi K; Suwa T
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1644-1646. PubMed ID: 38303369
[TBL] [Abstract] [Full Text] [Related]
9. MYC rearrangements in HIV-associated large B-cell lymphomas: EUROMYC, a European retrospective study.
Pagani C; Rusconi C; Dalla Pria A; Ravano E; Schommers P; Bastos-Oreiro M; Verga L; Gini G; Spina M; Arcaini L; Steffanoni S; Dalu D; Crucitti L; Lorenzi L; Balzarini P; Cattaneo C; Bongiovanni L; Rosenwald A; Facchetti F; Bower M; Ferreri AJM; Rossi G; Tucci A; Re A
Blood Adv; 2024 Feb; 8(4):968-977. PubMed ID: 38207206
[TBL] [Abstract] [Full Text] [Related]
10. Challenges identifying DLBCL patients with poor outcomes to upfront chemoimmunotherapy and its impact on frontline clinical trials.
Atallah-Yunes SA; Khurana A; Maurer M
Leuk Lymphoma; 2024 Apr; 65(4):430-439. PubMed ID: 38180317
[TBL] [Abstract] [Full Text] [Related]
11. Circulating-tumor DNA Assessment in Diffuse Large B-cell lymphoma to Determine Up-front Stem Cell Transplantation: A Pilot Study.
Kim J; LE TM; Lee D; Nguyen HDT; Cho HJ; Sohn SK; Kim JG; Jeong SY; Ham JY; Jeong JY; Han HS; Moon JH; Baek DW
In Vivo; 2024; 38(1):372-379. PubMed ID: 38148060
[TBL] [Abstract] [Full Text] [Related]
12. The pretreatment Controlling Nutritional Status score is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma.
Kaneda Y; Kanemura N; Nakamura N; Ikoma Y; Yamaguchi K; Takada E; Shibata Y; Lee S; Fujita K; Morishita T; Matsumoto T; Nakamura H; Kitagawa J; Kasahara S; Hara T; Tsurumi H; Shimizu M
Leuk Lymphoma; 2024 Mar; 65(3):339-345. PubMed ID: 38124378
[TBL] [Abstract] [Full Text] [Related]
13. Use of genome-wide DNA methylation analysis to identify prognostic CpG site markers associated with longer survival time in dogs with multicentric high-grade B-cell lymphoma.
Teoh YB; Ishizaki T; Kagawa Y; Yokoyama S; Jelinek J; Matsumoto Y; Tomiyasu H; Tsujimoto H; Takiguchi M; Yamazaki J
J Vet Intern Med; 2024; 38(1):316-325. PubMed ID: 38115210
[TBL] [Abstract] [Full Text] [Related]
14. [The Clinical-Biological Features and prognosis of Patients with Mantle Cell lymphoma].
Chen WZ; Liu TB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1726-1732. PubMed ID: 38071052
[TBL] [Abstract] [Full Text] [Related]
15. Genetic Characterization of Primary Mediastinal B-Cell lymphoma: Pathogenesis and Patient Outcomes.
Noerenberg D; Briest F; Hennch C; Yoshida K; Hablesreiter R; Takeuchi Y; Ueno H; Staiger AM; Ziepert M; Asmar F; Locher BN; Toth E; Weber T; Amini RM; Klapper W; Bouzani M; Poeschel V; Rosenwald A; Held G; Campo E; Ishaque N; Stamatopoulos K; Kanellis G; Anagnostopoulos I; Bullinger L; Goldschmidt N; Zinzani PL; Bödör C; Rosenquist R; Vassilakopoulos TP; Ott G; Ogawa S; Damm F
J Clin Oncol; 2024 Feb; 42(4):452-466. PubMed ID: 38055913
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic value of serum albumin level in patients with diffuse large B cell lymphoma.
Chen L; Pan L; Liu T
Acta Biochim Pol; 2023 Dec; 70(4):767-776. PubMed ID: 38051992
[TBL] [Abstract] [Full Text] [Related]
17. A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma.
Habringer S; Demel UM; Fietz AK; Lammer F; Schroers R; Hofer S; Bairey O; Braess J; Meier-Stiegen AS; Stuhlmann R; Schmidt-Hieber M; Hoffmann J; Zinngrebe B; Kaiser U; Reimer P; Möhle R; Fix P; Höffkes HG; Langenkamp U; Büschenfelde CMZ; Hopfer O; Stoltefuß A; La Rosée P; Blasberg H; Jordan K; Kaun S; Meurer A; Unteroberdörster M; von Brünneck AC; Capper D; Heppner FL; Chapuy B; Janz M; Schwartz S; Konietschke F; Vajkoczy P; Korfel A; Keller U
Eur J Cancer; 2024 Jan; 196():113436. PubMed ID: 38008033
[TBL] [Abstract] [Full Text] [Related]
18. Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell lymphoma: Results From the European Mantle Cell lymphoma Elderly Trial.
Hoster E; Delfau-Larue MH; Macintyre E; Jiang L; Stilgenbauer S; Vehling-Kaiser U; Salles G; Thieblemont C; Tilly H; Wirths S; Feugier P; Hübel K; Schmidt C; Ribrag V; Kluin-Nelemans JC; Dreyling M; Pott C;
J Clin Oncol; 2024 Feb; 42(5):538-549. PubMed ID: 37992261
[TBL] [Abstract] [Full Text] [Related]
19. Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.
Zhong Q; Chen H; Chen D; Qin Y; He X; Yang Y; Yang J; Liu P; Zhou S; Yang S; Zhou Y; Tang L; Chen C; Shi Y
Ann Hematol; 2024 Jan; 103(1):211-226. PubMed ID: 37861735
[TBL] [Abstract] [Full Text] [Related]
20. Poor Outcome of Adult T-Cell Leukemia/lymphoma with Current Available Therapy: An Experience of Two Centers.
Saeed H; Sandoval-Sus J; Castillo-Tokumori F; Dong N; Pullukkara JJ; Boisclair S; Brahim A; Walker D; Bridgellal S; Zhang L; Sokol L
Oncol Res Treat; 2023; 46(11):459-465. PubMed ID: 37844559
[TBL] [Abstract] [Full Text] [Related]
[Next]